🇺🇸 FDA

Company profile · Sponsor

Pierre

Pierre Fabre Médicament

ECE12DF · EMA pharma EU
Pipeline
3
Drugs
0
Patents
0

Quick answer

Pierre (ECE12DF) is a pharma company. headquartered in EU. listed on EMA. NovaPharmaNews links 3 pipeline programs, 0 drugs, and 0 patents to this profile..

Company facts

Ticker ECE12DF
Exchange EMA
Company type pharma
Headquarters EU

Pipeline (3)

Search pipeline →

  1. Gardasil 9 suspension for injection. Human Papillomavirus 9-valent Vaccine (Recombinant, adsorbed)

    Pierre

    giving a commercially available vaccine to women with HIV under treatment, women living with HIV traeted by antiretroviral

    approved small molecule active

    1 trial

  2. LIDOCAINE HYDROCHLORIDE, MORPHINE HYDROCHLORIDE

    Pierre

    sickle cell anaemia

    approved small molecule active

    1 trial

  3. The impact of extra-fine inhalation corticosteroid particles on small-airway disease in Chronic Obstructive Pulmonary Disease (COPD): a randomized, prospective cross-over trial.

    Pierre

    Chronic Obstructive Pulmonary Disease

    approved other active

    1 trial

Frequently asked questions

What is Pierre?

Pierre (ECE12DF) is a pharma company. headquartered in EU. listed on EMA. NovaPharmaNews links 3 pipeline programs, 0 drugs, and 0 patents to this profile..

What pipeline programs does Pierre sponsor?

We track 3 ClinicalTrials.gov-linked programs for Pierre, including Gardasil 9 suspension for injection. Human Papillomavirus 9-valent Vaccine (Recombinant, adsorbed) and 2 more. Open each program for phase, modality, NCT IDs, and indication details.

Where does Pierre company data come from?

Profiles combine SEC EDGAR (CIK/ticker), ClinicalTrials.gov sponsor links, FDA drug records, and USPTO patent metadata. See our data sources page. This profile is for professional reference, not investment advice.